Long Ideas - As the world’s largest biotechnology company, with a market capitalization well on its way to $70 billion, Amgen (NASDAQ:AMGN) represents the “old guard” of biotechnology. … Continue Reading
Read NowLong Ideas - PharmAthene Inc. (AMEX:PIP) announced on Thursday that the Delaware Supreme Court heard oral arguments in ongoing litigation with SIGA Technologies (NASDAQ:SIGA), and a previous ruling … Continue Reading
Read NowLong Ideas - SciClone Pharmaceuticals (NASDAQ:SCLN) issued 2013 financial guidance earlier this week around the JP Morgan Healthcare Conference in San Francisco, with its earnings outlook anticipated to … Continue Reading
Read NowLong Ideas - With a gain of more than 27% over the past year, Celgene (NASDAQ:CELG) serves as a solid example of the balance between stability and growth … Continue Reading
Read NowLong Ideas - Affymax (NASDAQ:AFFY) and partner Takeda announced Monday that Omontys, their erythropoietin stimulating agent (ESA), became the subject of a supply contract with dialysis supplier DSI … Continue Reading
Read NowLong Ideas - Keryx Biopharmaceuticals (NASDAQ:KERX) announced Monday morning that its Japanese development partner JT Tori Pharmaceutical Co. submitted a new drug application (NDA) for Zerenex, the company’s … Continue Reading
Read NowLong Ideas - Endo Health Solutions (NASDAQ:ENDP) re-established financial guidance Thursday night, re-affirming 2012’s prior outlook and, as expected, guiding expectations lower for revenue and EPS in 2013. This … Continue Reading
Read Now